Microwave ablation combined with apatinib and camrelizumab in patients with advanced hepatocellular carcinoma: A single-arm, preliminary study

PURPOSE: The aim of this study was to assess the safety and efficacy of microwave ablation combined with apatinib [vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor] and camrelizumab [anti-programmed death-1 (PD-1) antibody] in patients with advanced hepatocellular carcinoma (HCC). P...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Zhang, Qiao, Lu, Qiaorui, Cheng, Zhigang, Liu, Fangyi, Han, Zhiyu, Yu, Xiaoling, Yu, Jie, Liang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644054/
https://www.ncbi.nlm.nih.gov/pubmed/36389778
http://dx.doi.org/10.3389/fimmu.2022.1023983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644054/
https://www.ncbi.nlm.nih.gov/pubmed/36389778
http://dx.doi.org/10.3389/fimmu.2022.1023983

Ejemplares similares